Abstract 4395: SEA technology: A novel strategy for enhancing antibody effector function
Year: 2010
Type: conference-abstract
Source: Cancer Research
Institution: Seagen (United States)
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2067675598
